Macarbi CH Tablet Substitute
Composition:
AZILSARTAN-40MG + CHLORTHALIDONE-12.5MG
Uses:
Hypertension
Medicinal Benefits:
Macarbi CH Tablet is a combination of Azilsartan and Chlorthalidone. It is used to treat high blood pressure. Azilsartan is an angiotensin receptor blocker (ARB). It works by blocking the hormone angiotensin, thereby relaxing blood vessels. This allows the blood to flow more smoothly and the heart to pump more efficiently. Chlorthalidone is a diuretic that removes extra water and certain electrolytes from the body. Over time it also relaxes blood vessels and improves blood flow. Together, Macarbi CH Tablet helps treat high blood pressure.
Macarbi CH Tablet works by relaxing and widening the blood vessels. It also prevents fluid retention due to excess salt build-up. This helps the heart pump blood easily throughout the body, lowering blood pressure.
Macarbi CH Tablet can cause high levels of potassium in the blood leading to hyperkalaemia. Hence it is not recommended to use potassium supplements along with Macarbi CH Tablet . However, consult your doctor if you are already taking other medicines before starting Macarbi CH Tablet .
Chlorthalidone in Macarbi CH Tablet may affect blood sugar levels in people with diabetes. Hence, it is advised to regularly monitor your sugar levels while taking Macarbi CH Tablet . Your doctor may adjust the dose accordingly. Please seek medical advice for more information before starting Macarbi CH Tablet .
Even though your blood pressure becomes normal after using Macarbi CH Tablet , it may switch back to high ranges if you stop using it. Therefore, continue taking Macarbi CH Tablet for as long as your doctor has advised.
Macarbi CH Tablet may cause dehydration. It is advised to drink plenty of fluids and avoid heavy exercises and sports to prevent dehydration. If you experience extreme thirst and dry mouth for a longer period, please seek medical advice.
Consult your doctor before taking Macarbi CH Tablet with other medicines as Macarbi CH Tablet may increase the rate of gastrointestinal transit, which may affect the absorption of other orally administered medicines taken simultaneously.